Life
Briefing: FDA and NIH announce more initiatives to reduce animal testing in drug development
Strategic angle: The HHS has made reducing animal testing a priority over the past year.
editorial-staff
1 min read
Updated 24 days ago
The FDA and NIH have announced new initiatives aimed at decreasing reliance on animal testing within the drug development process. This aligns with the HHS's ongoing commitment to reduce animal use in research.
These initiatives may involve the adoption of advanced in vitro methods and computational models, which could enhance the efficiency and ethical standards of drug testing.
The move is part of a broader trend in regulatory science, seeking to improve the throughput of drug development while addressing ethical concerns associated with animal testing.